STRIVE AVXS-101-CL-303: A Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients with Spinal Muscular Atrophy Type 1 with One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infu

Project: Research project

Project Details

StatusActive
Effective start/end date10/1/17 → 8/31/50

Funding

  • AveXis, Inc.